| FRANKLIN EMERGING MARKETS DEBT OPPORTUNITIES HARD CURRENCY I (ACC) USD | RFI EMERGENTES HRD CCY | 8,92% | 24,78% | 16,36% | · |
| FRANKLIN EMERGING MARKETS DEBT OPPORTUNITIES HARD CURRENCY I (YDIS) EUR-H1 | RFI EMERGENTES HRD CCY | -1,81% | -0,42% | -28,76% | · |
| FRANKLIN EMERGING MARKETS DEBT OPPORTUNITIES HARD CURRENCY I (YDIS) USD | RFI EMERGENTES HRD CCY | 0,92% | 0,96% | -17,01% | · |
| FRANKLIN EMERGING MARKETS DEBT OPPORTUNITIES HARD CURRENCY W (ACC) USD | RFI EMERGENTES HRD CCY | 8,90% | 24,82% | 16,75% | · |
| FRANKLIN EMERGING MARKETS DEBT OPPORTUNITIES HARD CURRENCY W (YDIS) EUR-H1 | RFI EMERGENTES HRD CCY | -1,95% | -0,42% | -28,85% | · |
| FRANKLIN ESG-FOCUSED BALANCED FUND A (ACC) EUR | MIXTO FLEXIBLE | 10,45% | 33,12% | 25,42% | · |
| FRANKLIN ESG-FOCUSED BALANCED FUND A-H1 (YDIS) USD | MIXTO FLEXIBLE | 13,15% | 28,09% | 32,42% | · |
| FRANKLIN ESG-FOCUSED BALANCED FUND A (YDIS) EUR | MIXTO FLEXIBLE | 9,61% | 26,14% | 15,95% | · |
| FRANKLIN ESG-FOCUSED BALANCED FUND I-H1 (YDIS) USD | MIXTO FLEXIBLE | 13,10% | 29,89% | 35,96% | · |
| FRANKLIN ESG-FOCUSED BALANCED FUND I (YDIS) EUR | MIXTO FLEXIBLE | 9,54% | 27,70% | 18,92% | · |
| FRANKLIN ESG-FOCUSED BALANCED FUND W-H1 (YDIS) USD | MIXTO FLEXIBLE | 13,03% | 29,73% | 35,64% | · |
| FRANKLIN ESG-FOCUSED BALANCED FUND W (YDIS) EUR | MIXTO FLEXIBLE | 9,66% | 27,62% | 18,73% | · |
| FRANKLIN EUROPEAN TOTAL RETURN S (ACC) EUR | RFI EUROPA | 1,83% | 11,11% | -2,34% | · |
| FRANKLIN EUROPEAN TOTAL RETURN S (YDIS) EUR | RFI EUROPA | -1,13% | 1,51% | -13,49% | · |
| FRANKLIN EUROPEAN TOTAL RETURN W (YDIS) EUR | RFI EUROPA | -1,64% | 0,12% | -15,52% | · |
| FRANKLIN EURO SHORT DURATION BOND EB (ACC) EUR | RF EURO CORTO PLAZO | 1,58% | 10,55% | · | · |
| FRANKLIN FLEXIBLE ALPHA BOND W (ACC) USD | RFI GLOBAL | 4,86% | 14,12% | 24,36% | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) USD | RVI BIOTECNOLOGÍA | 39,95% | 16,82% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (YDIS) EUR | RVI BIOTECNOLOGÍA | 38,05% | 16,43% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS C (ACC) USD | RVI BIOTECNOLOGÍA | 39,31% | 14,81% | · | · |
